Lilly Sees More Dealmaking as GLP-1 Wins Expand Market
Eli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
A succinct guide to identifying the ETF with the best tax efficiency for dividend exposure, including key considerations and quick decision tips.
28,132 articlesEli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Two traders file a civil suit accusing Polymarket of misresolving a Strategy bitcoin sale market after a late May dis...
As U.S.-Iran tensions escalate, the cia’s social media guide has amassed millions of views, highlighting how geopolit...
Ripple XRP pushed past a major resistance, signaling a relief rally amid a cautious crypto backdrop. Traders weigh th...
A lithium-focused startup has joined the unicorn club after a surge in demand for EV batteries. The move signals a br...
A growing share of twenty-somethings hold two or more jobs and side hustles, raising questions about retirement readi...
As AI infrastructure spending persists into July, Teradyne, Ouster, and Vishay Precision Group lead a rally in infras...
A wave of review requests is reshaping consumer habits and small-business budgets in early 2026. Experts warn of a fe...
The AI boom has drawn big names into the stock market arena. This article breaks down what billionaire Stanley Drucke...
A May 14, 2026 filing shows Trump boosting crypto exposure by buying Coinbase and Bitcoin-related stocks, a notable m...
New disclosures on trump crypto ties allegations put regulatory scrutiny back in focus, as crypto markets react and i...
Eli Lilly stock could advance in the second half of 2026 as Foundayo gains traction and the GLP-1 franchise shines, b...